These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 26446253

  • 1. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
    Roehrs TA, Roth T.
    J Clin Sleep Med; 2016 Mar; 12(3):319-25. PubMed ID: 26446253
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.
    Randall S, Roehrs TA, Roth T.
    Sleep; 2012 Nov 01; 35(11):1551-7. PubMed ID: 23115404
    [Abstract] [Full Text] [Related]

  • 3. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
    Roehrs TA, Randall S, Harris E, Maan R, Roth T.
    J Psychopharmacol; 2012 Aug 01; 26(8):1088-95. PubMed ID: 22004689
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 01; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 5. Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.
    Roehrs TA, Randall S, Harris E, Maan R, Roth T.
    Sleep; 2011 Feb 01; 34(2):207-12. PubMed ID: 21286241
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1918254. PubMed ID: 31880796
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan 02; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 8. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK.
    J Clin Sleep Med; 2008 Jun 15; 4(3):229-34. PubMed ID: 18595435
    [Abstract] [Full Text] [Related]

  • 9. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
    Perlis ML, McCall WV, Krystal AD, Walsh JK.
    J Clin Psychiatry; 2004 Aug 15; 65(8):1128-37. PubMed ID: 15323600
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N, Hazra A, Das T.
    Indian J Pharmacol; 2013 Aug 15; 45(1):34-9. PubMed ID: 23543804
    [Abstract] [Full Text] [Related]

  • 11. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M.
    Sleep; 2013 Feb 01; 36(2):189-96. PubMed ID: 23372266
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May 01; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 13. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 14. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
    Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK.
    J Clin Psychiatry; 1999 Oct 15; 60(10):668-76. PubMed ID: 10549683
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.
    Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T.
    Sleep; 2011 Oct 01; 34(10):1433-42. PubMed ID: 21966075
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of almorexant in adult chronic insomnia: a randomized placebo-controlled trial with an active reference.
    Black J, Pillar G, Hedner J, Polo O, Berkani O, Mangialaio S, Hmissi A, Zammit G, Hajak G.
    Sleep Med; 2017 Aug 01; 36():86-94. PubMed ID: 28735928
    [Abstract] [Full Text] [Related]

  • 17. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.
    Roth T, Roehrs T, Vogel G.
    Sleep; 1995 May 01; 18(4):246-51. PubMed ID: 7618022
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 01; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.
    Sleep; 2009 Mar 01; 32(3):351-60. PubMed ID: 19294955
    [Abstract] [Full Text] [Related]

  • 20. A single-dose, randomized, double-blind, double dummy, placebo and positive-controlled, five-way cross-over study to assess the pharmacodynamic effects of lorediplon in a phase advance model of insomnia in healthy Caucasian adult male subjects.
    Horoszok L, Baleeiro T, D'Aniello F, Gropper S, Santos B, Guglietta A, Roth T.
    Hum Psychopharmacol; 2014 May 01; 29(3):266-73. PubMed ID: 24911577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.